The burden of rare cancers among adults in the Canton of Geneva, Switzerland, from 2011 to 2020.

ABSTRACT:

Introduction

Globally, cancer cases are expected to significantly increase due to population growth and aging, reaching 29.9 million by 2040 (+49.5% since 2022) and 32.6 million by 2045 (+63%), with countries like Switzerland forecasting a 36.5% increase. Rare cancers, defined as less than six cases/100,000 individuals/year, account for 15-24% for recent nationwide studies but they have fewer treatment options and lower survival rates. Using the Geneva Cancer Registry, we analyzed rare cancer incidence and survival rates in adults from the canton of Geneva, Switzerland (2011-2020), with the aim of informing future research at local and national levels.

Methods

We analyzed adult patients diagnosed with invasive cancers (2011-2020) in Geneva using Geneva Cancer Registry data,

SUBMITTER: Bot N 

PROVIDER: S-EPMC12009699 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature